These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 17996568)

  • 21. Identification of hibernating myocardium: a comparison between dobutamine echocardiography and study of perfusion and metabolism in patients with severe left ventricular dysfunction.
    Mariani MA; Palagi C; Donatelli F; Mengozzi G; Biadi O; Vanoli G; Landoni C; Paolini G; Lucignani G; Fazio F
    Am J Card Imaging; 1995 Jan; 9(1):1-8. PubMed ID: 7894227
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PET imaging in cardiology.
    Chacko GN
    Hell J Nucl Med; 2005; 8(3):140-4. PubMed ID: 16390017
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Usefulness of positron emission tomography in predicting long-term outcome in patients with diabetes mellitus and ischemic left ventricular dysfunction.
    Sawada S; Hamoui O; Barclay J; Giger S; Fain R; Foltz J; Fineberg N; Hutchins G
    Am J Cardiol; 2005 Jul; 96(1):2-8. PubMed ID: 15979422
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of myocardial viability assessed by technetium-99m-sestamibi SPECT and fluorine-18-FDG PET on clinical outcome in coronary artery disease.
    vom Dahl J; Altehoefer C; Sheehan FH; Buechin P; Schulz G; Schwarz ER; Koch KC; Uebis R; Messmer BJ; Buell U; Hanrath P
    J Nucl Med; 1997 May; 38(5):742-8. PubMed ID: 9170439
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of F-18 FDG positron emission tomography (PET) in the assessment of myocardial viability.
    Ghesani M; Depuey EG; Rozanski A
    Echocardiography; 2005 Feb; 22(2):165-77. PubMed ID: 15693785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of CABG-related risk in patients with CAD and LVD. Contribution of PET with [18F]FDG to the assessment of myocardial viability.
    Landoni C; Lucignani G; Paolini G; Zuccari M; Galli L; Di Credico G; Rossetti C; Pelenghi S; Gilardi MC; Fazio F; Grossi A
    J Cardiovasc Surg (Torino); 1999 Jun; 40(3):363-72. PubMed ID: 10412921
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myocardial scar and insulin resistance predict cardiovascular events in severe ischaemic myocardial dysfunction: a perfusion-metabolism positron emission tomography study.
    Feola M; Biggi A; Chauvie S; Vado A; Leonardi G; Rolfo F; Ribichini F
    Nucl Med Commun; 2008 May; 29(5):448-54. PubMed ID: 18391729
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Utility of positron emission tomography in predicting cardiac events and survival in patients with coronary artery disease and severe left ventricular dysfunction.
    Rohatgi R; Epstein S; Henriquez J; Ababneh AA; Hickey KT; Pinsky D; Akinboboye O; Bergmann SR
    Am J Cardiol; 2001 May; 87(9):1096-9, A6. PubMed ID: 11348609
    [No Abstract]   [Full Text] [Related]  

  • 29. Prognostic value of revascularising viable myocardium in elderly patients with stable coronary artery disease and left ventricular dysfunction: a PET/CT study.
    Namdar M; Rager O; Priamo J; Frei A; Noble S; Amzalag G; Ratib O; Nkoulou R
    Int J Cardiovasc Imaging; 2018 Oct; 34(10):1673-1678. PubMed ID: 29808386
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Validation of QGS and 4D-MSPECT for quantification of left ventricular volumes and ejection fraction from gated 18F-FDG PET: comparison with cardiac MRI.
    Schaefer WM; Lipke CS; Nowak B; Kaiser HJ; Reinartz P; Buecker A; Krombach GA; Buell U; Kühl HP
    J Nucl Med; 2004 Jan; 45(1):74-9. PubMed ID: 14734676
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic value of dobutamine echocardiography in patients with left ventricular dysfunction.
    Williams MJ; Odabashian J; Lauer MS; Thomas JD; Marwick TH
    J Am Coll Cardiol; 1996 Jan; 27(1):132-9. PubMed ID: 8522686
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extensive left ventricular remodeling does not allow viable myocardium to improve in left ventricular ejection fraction after revascularization and is associated with worse long-term prognosis.
    Bax JJ; Schinkel AF; Boersma E; Elhendy A; Rizzello V; Maat A; Roelandt JR; van der Wall EE; Poldermans D
    Circulation; 2004 Sep; 110(11 Suppl 1):II18-22. PubMed ID: 15364832
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preoperative positron emission tomographic viability assessment and perioperative and postoperative risk in patients with advanced ischemic heart disease.
    Haas F; Haehnel CJ; Picker W; Nekolla S; Martinoff S; Meisner H; Schwaiger M
    J Am Coll Cardiol; 1997 Dec; 30(7):1693-700. PubMed ID: 9385895
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Revascularization in severe left ventricular dysfunction: outcome comparison of drug-eluting stent implantation versus coronary artery by-pass grafting.
    Gioia G; Matthai W; Gillin K; Dralle J; Benassi A; Gioia MF; White J
    Catheter Cardiovasc Interv; 2007 Jul; 70(1):26-33. PubMed ID: 17585381
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Severe left ventricular dyssynchrony is associated with poor prognosis in patients with moderate systolic heart failure undergoing coronary artery bypass grafting.
    Penicka M; Bartunek J; Lang O; Medilek K; Tousek P; Vanderheyden M; De Bruyne B; Maruskova M; Widimsky P
    J Am Coll Cardiol; 2007 Oct; 50(14):1315-23. PubMed ID: 17903629
    [TBL] [Abstract][Full Text] [Related]  

  • 36. F-18-FDG uptake is a reliable predictory of functional recovery of akinetic but viable infarct regions as defined by magnetic resonance imaging before and after revascularization.
    Schmidt M; Voth E; Schneider CA; Theissen P; Wagner R; Baer FM; Schicha H
    Magn Reson Imaging; 2004 Feb; 22(2):229-36. PubMed ID: 15010115
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluorine 18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Cardiac Viability Risk Stratification in Comparison with EuroSCORE II for Revascularization in Patients with Left Ventricular Dysfunction.
    Thangamuthu BY; Elangovan I; Asra P; Simon S; Sathyamoorthy I
    Indian J Nucl Med; 2023; 38(2):110-114. PubMed ID: 37456177
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of inflamed aortic plaque in conventional fluorodeoxyglucose-positron emission tomography myocardial viability studies.
    Liu Y; Ghosh N; Dwivedi G; Chow BJ; deKemp RA; DaSilva J; Guo A; Garrard L; Beanlands RS; Ruddy TD
    Can J Cardiol; 2013 Sep; 29(9):1069-75. PubMed ID: 23664168
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spatial and temporal heterogeneity of regional myocardial uptake in patients without heart disease under fasting conditions on repeated whole-body 18F-FDG PET/CT.
    Inglese E; Leva L; Matheoud R; Sacchetti G; Secco C; Gandolfo P; Brambilla M; Sambuceti G
    J Nucl Med; 2007 Oct; 48(10):1662-9. PubMed ID: 17873124
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Positron emission tomography for assessment of viability.
    Sawada SG
    Curr Opin Cardiol; 2006 Sep; 21(5):464-8. PubMed ID: 16900009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.